TYSABRI

Concentrate for solution for infusion, 300mg/15ml
RxActive license

Active substance (INN)

natalizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength300mg/15ml
PackagingUkupno 1 bočica staklena sa 15ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerBiogen Netherlands B.V., Netherlands
Therapeutic groupAntineoplastic and immunomodulating agents (L04AG03)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateJune 11, 2025

Analogs in Montenegro

1

Other medicines with the same active substance

TYSABRIRx
Solution for injection in pre-filled syringe, 150mgBiogen Netherlands B.V.
Source: CInMED register